Known targets — ChEMBL curated mechanism
KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2
The experimentally established mechanism targets of Guanidine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 11/20 | 0.47 |
| ▸ | POLB | P06746 | 10/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 9/20 | 0.47 |
| ▸ | APEX1 | P27695 | 7/20 | 0.47 |
| ▸ | MAPT | P10636 | 7/20 | 0.47 |
| ▸ | RECQL | P46063 | 5/20 | 0.47 |
| ▸ | CTDSP1 | Q9GZU7 | 3/20 | 0.47 |
| ▸ | NSD2 | O96028 | 2/20 | 0.47 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PTPN7 | P35236 | 1/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 2/20 | 0.40 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | PKM | P14618 | 2/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8699884 | 0.83 | L3MBTL1 (0.46) | L3MBTL1POLBTDP1APEX1MAPT | |
| SCHEMBL7825527 | 0.83 | L3MBTL1 (0.56) | L3MBTL1POLBTDP1APEX1MAPT | |
| SCHEMBL7825532 | 0.83 | L3MBTL1 (0.56) | L3MBTL1POLBTDP1APEX1MAPT | |
| SCHEMBL7827403 | 0.83 | L3MBTL1 (0.56) | L3MBTL1POLBTDP1APEX1MAPT | |
| SCHEMBL7823379 | 0.81 | L3MBTL1 (0.47) | L3MBTL1POLBTDP1APEX1MAPT | |
| SCHEMBL7823376 | 0.81 | L3MBTL1 (0.47) | L3MBTL1POLBTDP1APEX1MAPT | |
| SCHEMBL7823383 | 0.80 | L3MBTL1 (0.44) | L3MBTL1POLBTDP1APEX1MAPT | |
| SCHEMBL8699888 | 0.78 | L3MBTL1 (0.43) | L3MBTL1POLBTDP1APEX1MAPT | |
| Guanidine SCHEMBL8700709 | 0.77 | POLB (0.34) | L3MBTL1POLBTDP1APEX1MAPT | |
| Guanidine SCHEMBL8705526 | 0.76 | AOC2 (0.49) | L3MBTL1POLBTDP1MAPTCTDSP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5824691-A | CARDIOVASCULAR, CEREBROVASCULAR, RENAL DISEASES; SHOCK, ARTERIOSCLEROSIS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-20 | — | — | US | disclosed |